デジタル糖尿病管理の世界市場：製品タイプ別、エンドユーザー別、コンポーネント別、地域別、範囲および予測

デジタル糖尿病管理の市場規模と予測

デジタル糖尿病管理市場は、2024年に171億1,000万米ドルと評価され、2024年から2031年にかけて13.10%のCAGRで成長し、2031年には464億6,000万米ドルに達すると予測されています。デジタル糖尿病管理とは、糖尿病のモニタリング、管理、治療のためにデジタル技術と接続デバイスを使用し、患者と医療提供者の両方にリアルタイムのデータと洞察を提供することです。これらのソリューションには、スマート血糖測定器からインスリン送達システムまで、さまざまな製品が含まれ、血糖コントロールの改善、患者エンゲージメントの強化、糖尿病関連合併症リスクの低減を目指しています。

デジタル糖尿病管理の将来の展望は、人工知能、機械学習、ビッグデータ解析を統合して、よりパーソナライズされた予測治療を提供することにあり、糖尿病治療と予防戦略に革命をもたらす可能性があります。

世界のデジタル糖尿病管理市場力学

世界のデジタル糖尿病管理市場を形成している主な市場力学は以下の通り：

主な市場促進要因

糖尿病の有病率の上昇：

特に新興国市場における糖尿病患者の世界の急増により、病状を効果的に監視・管理するための効率的なデジタル管理ツールに対するニーズが高まっており、市場の成長を後押ししています。

技術の進歩：

センサー、モバイル技術、データ分析における技術革新により、デジタル糖尿病管理ツールが大幅に改善され、患者とヘルスケアプロバイダーの双方にとって、より使いやすく、正確で効率的なものとなっています。

コネクテッドデバイスの普及：

スマートフォンやウェアラブル技術の普及は、デジタル糖尿病管理ソリューションの普及を促進し、患者と医療従事者間のコミュニケーションを強化し、より良いケアコーディネーションを実現します。

予防ヘルスケアへの注力：

予防ヘルスケアと個別化医療へのシフトにより、糖尿病の早期発見と予防的管理のためのデジタルツールの利用が増加し、長期的な合併症の減少と患者の予後の改善が期待されています。

主な課題

データのプライバシーとセキュリティへの懸念：

機密性の高い健康データの収集とトランスミッションは、プライバシーとサイバーセキュリティに重大な懸念をもたらし、世界の糖尿病デジタル管理市場の成長を妨げる可能性があります。

規制上のハードル：

様々な地域における医療機器やソフトウェアに対する厳しい規制要件は、製品の承認や市場参入を遅らせる可能性があり、革新的な糖尿病管理ソリューションの導入を目指す企業にとって課題となります。

主要動向：

人工知能の統合：

糖尿病管理ツールに人工知能と機械学習を組み込むことで、予測的洞察と個別化された推奨が提供され、これらのソリューションの有効性とユーザー体験が向上します。

遠隔医療の台頭：

COVID-19の大流行によって加速した遠隔医療の受け入れ拡大は、患者ケアの強化のためにデジタル糖尿病管理ソリューションに遠隔モニタリングやバーチャル診察機能を採用することを大きく後押ししています。

エコシステム・アプローチ：

糖尿病管理における包括的なエコシステム・アプローチを採用する企業が増えており、さまざまな機器、アプリケーション、サービスを統合することで、患者に全体的かつ協調的なケア体験を提供しています。

目次

第1章 世界のデジタル糖尿病管理市場：イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査タイムライン
• 前提条件
• 限界

第2章 検証市場調査の調査手法

• データマイニング
• データの三角測量
• ボトムアップアプローチ
• トップダウンアプローチ
• 調査の流れ
• 業界専門家からの重要な洞察
• データソース

第3章 エグゼクティブサマリー

• 市場概要
• エコロジーマッピング
• 絶対的収益機会
• 市場の魅力
• デジタル糖尿病管理の世界市場地域別分析（CAGR）
• デジタル糖尿病管理の世界市場：製品別（金額）
• デジタル糖尿病管理の世界市場：タイプ別（金額）
• デジタル糖尿病管理の世界市場：用途別（金額）
• 今後の市場機会
• 世界市場分割
• 製品ライフライン

第4章 デジタル糖尿病管理の世界市場展望

• デジタル糖尿病管理の世界進化
• 促進要因
• 抑制要因
• 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析
• 価格分析
• マクロ経済分析

第5章 デジタル糖尿病管理の世界市場：製品別

• 概要
• スマートグルコースメーター
• 持続血糖モニタリングシステム
• スマートインスリンペン
• スマートインスリンポンプ
• APPS類

第6章 デジタル糖尿病管理の世界市場：タイプ別

• 概要
• ウェアラブルデバイス
• ハンドヘルド機器

第7章 デジタル糖尿病管理の世界市場：エンドユーザー別

• 概要
• 病院
• 在宅セット
• 診断センター

第8章 デジタル糖尿病管理の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ
• 中東・アフリカ
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第9章 世界のデジタル糖尿病管理市場：競合情勢

• 概要
• 各社の市場ランキング
• 主な発展
• 地域別フットプリント
• 企業の業界フットプリント
• ACE MATRIX

第10章 企業プロファイル

• ABBOTT LABORATORIES
• MEDTRONIC PLC
• F. HOFFMANN-LA ROCHE LTD.
• BAYER AG
• LIFESCAN, INC.
• DEXCOM, INC.
• SANOFI
• INSULET CORPORATION
• ASCENSIA DIABETES CARE HOLDINGS AG
• B BRAUN MELSUNGEN AG
• ABOUT VERIFIED MARKET RESEARCH
• DYNAMIC DATA VISUALIZATION

Digital Diabetes Management Market Size And Forecast

Digital Diabetes Management Market was valued at USD 17.11 Billion in 2024 and is projected to reach USD 46.46 Billion by 2031 growing at a CAGR of 13.10% from 2024 to 2031. Digital Diabetes Management refers to the use of digital technologies and connected devices to monitor, manage and treat diabetes, providing real-time data and insights to both patients and healthcare providers. These solutions encompass a range of products from smart glucose meters to insulin delivery systems, aiming to improve glycemic control, enhance patient engagement and reduce the risk of diabetes-related complications.

The future scope of digital diabetes management lies in the integration of artificial intelligence, machine learning and big data analytics to provide more personalized and predictive care, potentially revolutionizing diabetes treatment and prevention strategies.

Global Digital Diabetes Management Market Dynamics

The key market dynamics that are shaping the global digital diabetes management market include:

Key Market Drivers:

Rising Prevalence of Diabetes:

The global surge in diabetes cases, especially in developing regions, is increasing the need for efficient digital management tools to monitor and control the condition effectively, boosting market growth.

Technological Advancements:

Innovations in sensors, mobile technology and data analytics are significantly improving digital diabetes management tools, making them more user-friendly, precise and efficient for both patients and healthcare providers globally.

Growing Adoption of Connected Devices:

The widespread use of smartphones and wearable technology is driving greater adoption of digital diabetes management solutions, enhancing communication between patients and healthcare providers for better care coordination.

Focus on Preventive Healthcare:

The shift towards preventive healthcare and personalized medicine is increasing the use of digital tools for early diabetes detection and proactive management, reducing long-term complications and improving patient outcomes.

Key Challenges:

Data Privacy and Security Concerns:

The collection and transmission of sensitive health data pose significant privacy and cybersecurity concerns, which can hinder the growth of the global diabetes digital management market.

Regulatory Hurdles:

Strict regulatory requirements for medical devices and software across various regions can delay product approvals and market entry, creating challenges for companies aiming to introduce innovative diabetes management solutions.

Key Trends:

Integration of Artificial Intelligence:

The incorporation of artificial intelligence and machine learning into diabetes management tools is providing predictive insights and personalized recommendations, enhancing the effectiveness and user experience of these solutions.

Rise of Telemedicine:

The growing acceptance of telemedicine, accelerated by the COVID-19 pandemic, is significantly driving the adoption of remote monitoring and virtual consultation features within digital diabetes management solutions for enhanced patient care.

Ecosystem Approach:

Companies are increasingly adopting a comprehensive ecosystem approach in diabetes management, integrating various devices, applications and services to provide a holistic and coordinated care experience for patients.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Digital Diabetes Management Market Regional Analysis

Here is a more detailed regional analysis of the global digital diabetes management market:

North America:

According to Verified Market Research, North America is expected to dominate the Global digital diabetes management market.

The region benefits from advanced healthcare infrastructure, high diabetes prevalence and early adoption of digital health technologies, driving its market dominance in the sector.

Strong presence of major market players and favorable reimbursement policies in countries like the U.S. and Canada contribute to the region's leading position.

The growing emphasis on value-based care and patient-centric approaches in North America supports the adoption of digital diabetes management solutions.

Increasing investments in digital health startups and collaborations between technology companies and healthcare providers fuel innovation in the region.

Asia-Pacific:

According to Verified Market Research, Asia-Pacific is the fastest growing region in Global digital diabetes management market.

The Asia-Pacific region is experiencing a rapid increase in diabetes prevalence, creating a significant demand for effective management solutions.

Rising disposable incomes, improving healthcare infrastructure and increasing awareness about diabetes management in countries like China and India drive market growth.

Government initiatives to promote digital health and improve diabetes care in several Asian countries contribute to the rapid adoption of digital management tools.

The large population base and increasing penetration of smartphones and internet connectivity in the region support the swift market expansion.

Global Digital Diabetes Management Market Segmentation Analysis

The Global Digital Diabetes Management Market is Segmented on the Basis of Product, Type, End-User, And Geography.

Digital Diabetes Management Market, By Product

• Smart Glucose Meters
• Continuous Glucose Monitoring Systems
• Smart Insulin Pens
• Smart Insulin Pumps
• Others

Based on Product, the Digital Diabetes Management market is segmented into Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps and Others. Continuous Glucose Monitoring Systems (CGMs) are the most dominating product segment, driven by their ability to provide real-time, continuous glucose data without the need for frequent finger pricks. The increasing preference for CGMs among both Type 1 and Type 2 diabetes patients, coupled with their integration with insulin delivery systems, contributes significantly to their market dominance.

Digital Diabetes Management Market, By Type

• Wearable Devices
• Handheld Devices

Based on Type, the Digital Diabetes Management market is categorized into Wearable Devices and Handheld Devices. Wearable Devices are the most dominating type, driven by their convenience, continuous monitoring capabilities and seamless integration with smartphones and other connected devices. The growing consumer preference for non-invasive and discreet monitoring solutions, along with advancements in sensor technologies, supports the dominance of wearable devices in the digital diabetes management market.

Digital Diabetes Management Market, By End-User

• Hospitals & Specialty Clinics
• Home Care Settings
• Academic & Research Institutes

Based on End-User, the Digital Diabetes Management market is segmented into Hospitals & Specialty Clinics, Home Care Settings and Academic & Research Institutes. Home Care Settings is the most dominating end-user segment, driven by the increasing trend towards self-management of diabetes and the growing preference for remote monitoring solutions. The convenience and cost-effectiveness of managing diabetes at home, coupled with the rising adoption of telemedicine, contribute significantly to the dominance of this segment.

Digital Diabetes Management Market, By Component

• Devices
• Apps & Software
• Services

Based on Component, the Digital Diabetes Management market is segmented into Devices, Apps & Software and Services. Devices are the most dominating component, driven by the essential role of hardware in glucose monitoring and insulin delivery. The continuous innovations in device technologies, such as improved accuracy, miniaturization and connectivity features, support their significant market share and dominance in the digital diabetes management ecosystem.

Digital Diabetes Management Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Based on Geography, the Digital Diabetes Management market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. North America is both the largest and one of the fastest-growing regions, driven by high diabetes prevalence, advanced healthcare infrastructure and early adoption of digital health technologies. The region's strong focus on innovation, favorable reimbursement policies and presence of key market players contribute significantly to its market dominance and continued rapid growth.

Key Players

• The Global "Digital Diabetes Management Market" study report will provide valuable insight with an emphasis on the global market. The major players in the Digital Diabetes Management Market include
• Medtronic, Dexcom, Inc., Insulet Corporation, Abbott Laboratories, Tandem Diabetes Care, Lifescan, Inc., Ascensia Diabetes Care, Tidepool, Glooko, Inc. and H2 Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

• Digital Diabetes Management Market Recent Developments
• In January 2024, Medtronic launched an advanced closed-loop insulin delivery system with enhanced AI capabilities, aiming to improve glucose control and reduce the burden of diabetes management for patients.
• In March 2024, Dexcom, Inc. announced a partnership with a major telehealth provider to integrate its CGM data into virtual diabetes care platforms, expanding access to remote monitoring and management services.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 DATA MINING
• 2.2 DATA TRIANGULATION
• 2.3 BOTTOM-UP APPROACH
• 2.4 TOP-DOWN APPROACH
• 2.5 RESEARCH FLOW
• 2.6 KEY INSIGHTS FROM INDUSTRY EXPERTS
• 2.7 DATA SOURCES

3 EXECUTIVE SUMMARY

• 3.1 MARKET OVERVIEW
• 3.2 ECOLOGY MAPPING
• 3.3 ABSOLUTE MARKET OPPORTUNITY
• 3.4 MARKET ATTRACTIVENESS
• 3.5 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
• 3.6 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT (USD MILLION)
• 3.7 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE (USD MILLION)
• 3.8 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY APPLICATION (USD MILLION)
• 3.9 FUTURE MARKET OPPORTUNITIES
• 3.10 GLOBAL MARKET SPLIT
• 3.11 PRODUCT LIFE LINE

4 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET OUTLOOK

• 4.1 GLOBAL DIGITAL DIABETES MANAGEMENT EVOLUTION
• 4.2 DRIVERS
  • 4.2.1 DRIVER 1
  • 4.2.2 DRIVER 2
• 4.3 RESTRAINTS
  • 4.3.1 RESTRAINT 1
  • 4.3.2 RESTRAINT 2
• 4.4 OPPORTUNITIES
  • 4.4.1 OPPORTUNITY 1
  • 4.4.2 OPPORTUNITY 2
• 4.5 PORTERS FIVE FORCE MODEL
• 4.6 VALUE CHAIN ANALYSIS
• 4.7 PRICING ANALYSIS
• 4.8 MACROECONOMIC ANALYSIS

5 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT

• 5.1 OVERVIEW
• 5.2 SMART GLUCOSE METER
• 5.3 CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM
• 5.4 SMART INSULIN PENS
• 5.5 SMART INSULIN PUMPS
• 5.6 APPS

6 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 WEARABLE DEVICES
• 6.3 HANDHELD DEVICES

7 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY END-USER

• 7.1 OVERVIEW
• 7.2 HOSPITALS
• 7.3 HOME SETTINGS
• 7.4 DIAGNOSTIC CENTERS EXTERIOR

8 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 U.S.
  • 8.2.2 CANADA
  • 8.2.3 MEXICO
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 U.K.
  • 8.3.3 FRANCE
  • 8.3.4 ITALY
  • 8.3.5 SPAIN
  • 8.3.6 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 JAPAN
  • 8.4.3 INDIA
  • 8.4.4 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 BRAZIL
  • 8.5.2 ARGENTINA
  • 8.5.3 REST OF LATIN AMERICA
• 8.6 MIDDLE-EAST AND AFRICA
  • 8.6.1 UAE
  • 8.6.2 SAUDI ARABIA
  • 8.6.3 SOUTH AFRICA
  • 8.6.4 REST OF MIDDLE-EAST AND AFRICA

9 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPANY MARKET RANKING
• 9.3 KEY DEVELOPMENTS
• 9.4 COMPANY REGIONAL FOOTPRINT
• 9.5 COMPANY INDUSTRY FOOTPRINT
• 9.6 ACE MATRIX

10 COMPANY PROFILES

• 10.1 ABBOTT LABORATORIES
  • 10.1.1 COMPANY OVERVIEW
  • 10.1.2 COMPANY INSIGHTS
  • 10.1.3 PRODUCT BENCHMARKING
  • 10.1.4 KEY DEVELOPMENT
  • 10.1.5 WINNING IMPERATIVES
  • 10.1.6 CURRENT FOCUS & STRATEGIES
  • 10.1.7 THREAT FROM COMPETITION
  • 10.1.8 SWOT ANALYSIS
• 10.2 MEDTRONIC PLC
• 10.3 F. HOFFMANN-LA ROCHE LTD.
• 10.4 BAYER AG
• 10.5 LIFESCAN, INC.
• 10.6 DEXCOM, INC.
• 10.7 SANOFI
• 10.8 INSULET CORPORATION
• 10.9 ASCENSIA DIABETES CARE HOLDINGS AG
• 10.10 B BRAUN MELSUNGEN AG
• 10.11 ABOUT VERIFIED MARKET INTELLIGENCE
• 10.12 DYNAMIC DATA VISUALIZATION